Cutler Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13,259
| Closed | -$64K | – | 2593 |
|
|
2022
Q2 | $64K | Buy |
13,259
+10,651
| +408% | +$51.4K | ﹤0.01% | 810 |
|
|
2022
Q1 | $24K | Buy |
+2,608
| New | +$24K | ﹤0.01% | 1303 |
|
|
2021
Q4 | – | Sell |
-625
| Closed | -$7K | – | 2798 |
|
|
2021
Q3 | $7K | Hold |
625
| – | – | ﹤0.01% | 1800 |
|
|
2021
Q2 | $11K | Hold |
625
| – | – | ﹤0.01% | 1699 |
|
|
2021
Q1 | $9K | Hold |
625
| – | – | ﹤0.01% | 1666 |
|
|
2020
Q4 | $7K | Hold |
625
| – | – | ﹤0.01% | 1520 |
|
|
2020
Q3 | $8K | Hold |
625
| – | – | ﹤0.01% | 1366 |
|
|
2020
Q2 | $6K | Hold |
625
| – | – | ﹤0.01% | 1315 |
|
|
2020
Q1 | $5K | Sell |
625
-208
| -25% | -$1.66K | ﹤0.01% | 1216 |
|
|
2019
Q4 | $7K | Sell |
833
-125
| -13% | -$1.05K | ﹤0.01% | 1291 |
|
|
2019
Q3 | $5K | Buy |
958
+133
| +16% | +$694 | ﹤0.01% | 1289 |
|
|
2019
Q2 | $13K | Sell |
825
-975
| -54% | -$15.4K | ﹤0.01% | 1236 |
|
|
2019
Q1 | $30K | Hold |
1,800
| – | – | ﹤0.01% | 967 |
|
|
2018
Q4 | $20K | Buy |
1,800
+1,475
| +454% | +$16.4K | ﹤0.01% | 1101 |
|
|
2018
Q3 | $13K | Sell |
325
-25
| -7% | -$1K | ﹤0.01% | 1256 |
|
|
2018
Q2 | $9K | Sell |
350
-5,000
| -93% | -$129K | ﹤0.01% | 1332 |
|
|
2018
Q1 | $81K | Buy |
5,350
+4,800
| +873% | +$72.7K | 0.01% | 814 |
|
|
2017
Q4 | $17K | Buy |
+550
| New | +$17K | ﹤0.01% | 1453 |
|